- Marlborough, MA
- Acton Pharmaceuticals is a specialty pharmaceutical company that develops and markets products for the treatment of respiratory conditions.
- John Simon, Daniel Kreisler
- Pharmaceutical, Health Care, Biotechnology
Acton Pharmaceuticals, Inc. is a specialty pharmaceutical company focusing on acquiring, developing and commercializing products primarily for the treatment of respiratory conditions.
The Company was founded by pharmaceutical executives experienced in respiratory product development and commercialization.
Acton is actively pursing the acquisition of products in either late-stage clinical development or which are currently being marketed.
Funding Rounds (4) - $36.7MUpdate
Board Members and Advisors (2)Update
|Oct 21, 2013||news.cision.com - Acquisition of Acton Pharmaceuticals completed|
|Sep 1, 2013||FinSMEs - FinSMEs|
|Aug 30, 2013||Xconomy - Meda Snaps Up Sequoia-Backed Acton Pharmaceuticals for $135M+|
|Aug 30, 2013||Business Wire - Acton Pharmaceuticals, Inc. to Be Acquired by Meda for Up to $200 Million|
|May 24, 2013||SEC - SEC FORM D|
|Oct 3, 2010||(see Boston Tech Flash) - Acton Pharmaceuticals raises 14200000 in venture round|
|Jan 26, 2010||Xconomy - Under the Radar Deals: 20-Something New England December Financings Worth $1M or Less|
|Jan 11, 2010||Xconomy - Quattro Scooped Up By Apple, Medtronic Invests in GI Dynamics, EMC Acquires Archer, & More Boston-Area Deals News|
225 Cedar Hill Street
Marlborough, MA 01752